News & Events
Stay informed with the latest news, scientific advancements, company milestones, and industry insights as we continue to push the boundaries of research and innovation.

News & Articles
CIMA Sciences Highlights OWLiver Findings in Landmark Lancet LITMUS Study on Noninvasive MASLD Testing
A Clinical Perspective: Bringing Liver Health into Both Lipid and Primary Care Practices
A Wiser Way to Assess Fatty Liver Disease
As Obesity Treatment Advances, Early Liver Disease Detection Matters More Than Ever
When Obesity Complicates Liver Disease Assessment
How OWLiver Delivers a Complete Picture of Liver Health
Earlier Insight, Better Care: Transforming the MASLD Journey
Obesity, Diabetes and Liver Disease: Why Early Detection Changes Everything
Enhancing MASLD Risk Stratification: Integrating FIB-4 with the MASEF Score
Cima Sciences to exhibit at the 2025 AASLD The Liver Meeting
Cima Sciences to exhibit at the 85th ADA Scientific Sessions with Rubió Metabolomics
Cima Sciences responds to the call-to-action in the 2025 Consensus Report from the American Diabetes Association
Cima Sciences presents new data at The Liver Meeting 2024
Order OWLiver® Test
OWLiver® is a non-invasive blood test to assess MASLD. It analyzes a panel of biomarkers through metabolomics methodology.
